IDPC marks Human Rights Day 2024 by shining a light on setbacks, key progress and promising avenues to better align drug policies and human rights standards.
Dertadian and Sentas examine community members' drug policy preferences, noting widespread support for non-punitive responses, yet skepticism regarding politicians' capacity to effect change.
Prioritising harm reduction efforts, public health and safeguarding rights are key to combatting rising opposition to Canada's historically bold drug policies and increasingly toxic supply.
TNI, GDPO and WOLA engage with six European countries to discuss trends towards reform in cannabis policy, offering innovative solutions for legal tensions, coordination and policy development.
The interim report makes recommendations in favour of decriminalisation, enhancing treatment options, expanded harm reduction options, and addressing social inequity.
In the Netherlands, rising drug-related violence and dangerous fluctuations in the contents of ecstasy pills spark recent calls for a legally regulated MDMA supply, with profits reinvested into harm reduction programmes.
Join experts in a webinar hosted by WOLA as they explore adverse effects of militarised drug policies and the need for effective, rights-based solutions to the overdose crisis.
Queirolo et al. qualitatively explore the unintended emergence of a cannabis 'grey market' under Uruguay's decade-old legalisation model, highlighting key challenges in policy implementation.